Markus Puhlmann - 24 Jan 2024 Form 4 Insider Report for Perspective Therapeutics, Inc. (CATX)

Role: Chief Medical Officer
Signature: /s/ Markus Puhlmann
Issuer symbol: CATX
Transactions as of: 24 Jan 2024
Net transactions value: +$139,888
Form type: 4
Filing time: 26 Jan 2024, 17:40:04 UTC
Previous filing: 19 Dec 2023
Next filing: 24 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CATX	Common Stock	Purchase	$139,888	+280,000	+26%	$0.4996	1,375,425	24 Jan 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4871 to $0.5000, inclusive. The reporting person undertakes to provide to Perspective Therapeutics, Inc., any security holder of Perspective Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

Content

This price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4871 to $0.5000, inclusive. The reporting person undertakes to provide to Perspective Therapeutics, Inc., any security holder of Perspective Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.